Home/ Supplements/ Niacin/ B4 Thermogenic 710 mg

B4 Thermogenic 710 mg

product on market Capsule BPI Sports Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Niacin supports energy metabolism, while the proprietary blend targets thermogenesis and workout performance. However, there is limited evidence available for this specific formulation due to the proprietary nature of the blend. The overall evidence coverage for these ingredients in this combination is very low.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for B4 Thermogenic 710 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

30 mg (150% DV)
2.1× RDA — within safe limits 196 studies (A:5, B:63)
Pre-Workout & Fat Burning Super Blend (Proprietary)
680 mg

Other Ingredients

Gelatin Microcrystalline Cellulose Magnesium Stearate Candurin Silver Fine FD&C Blue No. 1
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Take 1 capsule 20-30 mins prior to training

Once daily

Suggested Use: Take one (1) serving (1 capsule) 20-30 minutes before training, or as directed by a qualified healthcare practitioner. On non-training days, take one (1) serving (1 capsule) for continued support of fat burning capacity.

Warnings & Precautions

Warnings: Not intended for use by persons under age 18.

Do not exceed recommended dose.

Get the consent of a licensed physician before using this product, especially if you are taking medication, have a medical condition, you are pregnant, nursing or thinking about becoming pregnant.

Keep this product and all supplements out of the reach of children.

Caffeine Warning: The recommended serving of this product contains approximately as much caffeine as three cups of coffee.

Do not consume caffeine, or combine with synephrine, including but not limited to coffee, tea, soda and other dietary supplements or medications containing phenylephrine or caffeine.

Too much caffeine may cause nervousness, irritability, sleeplessness, and occasionally rapid heartbeat. Discontinue use if you experience dizziness, severe headache, rapid heartbeat or shortness of breath.

Caution: B4 contains the B vitamin niacin.

Niacin may cause temporary flushing, tingling, skin reddening, and sensations of heat, especially if taken on an empty stomach. This is a common reaction.

Formulation Notes

Caffeine Warning: The recommended serving of this product contains approximately as much caffeine as three cups of coffee.

Caution: B4 contains the B vitamin niacin.

Additional Information

When combined with a proper exercise and nutrition regimen. Statements based on early-stage independent 3rd party in vivo and / or in vitro model scientific research data findings for individual ingredients.

Rev. 01-011-B4P001 06/16

To report an adverse event or for more information call: 954.926.0900 (tel)

Facebook www.facebook.com/BPIonline

The once-daily fat burner

CNS stimulant Dopamine modulator Adipose tissue regulator

Fat burner

Metadata

Product Details

UPC / SKU8 51780 00485 2
DSLD Entry Date2017-10-21
Product TypeOther Combinations
FormCapsule
DSLD ID79860
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.